EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Comparison of Uric Acid Elevation between Aspirin-Ticagrelor and Aspirin-Prasugrel during Dual Antiplatelet Therapy: A Pilot Study

Seo-Won Kang, So-Jin Park, Jae-Hyun Lee, Yong-Seok Lee, Myung-Sook Min

Journal of Pharmacoepidemiology and Risk Management · 2022

DOI: 10.56142/2022.14.1.51 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacoepidemiology and Risk Management, 2022. Verfasst von Seo-Won Kang und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kang, S., Park, S., Lee, J., Lee, Y., & Min, M. (2022). Comparison of Uric Acid Elevation between Aspirin-Ticagrelor and Aspirin-Prasugrel during Dual Antiplatelet Therapy: A Pilot Study. Journal of Pharmacoepidemiology and Risk Management. https://doi.org/10.56142/2022.14.1.51

Vancouver

Kang S, Park S, Lee J, Lee Y, Min M. Comparison of Uric Acid Elevation between Aspirin-Ticagrelor and Aspirin-Prasugrel during Dual Antiplatelet Therapy: A Pilot Study. Journal of Pharmacoepidemiology and Risk Management. 2022. doi:10.56142/2022.14.1.51

BibTeX
@article{Kang2022,
  author = {Kang, Seo-Won and Park, So-Jin and Lee, Jae-Hyun and Lee, Yong-Seok and Min, Myung-Sook},
  title = {Comparison of Uric Acid Elevation between Aspirin-Ticagrelor and Aspirin-Prasugrel during Dual Antiplatelet Therapy: A Pilot Study},
  journal = {Journal of Pharmacoepidemiology and Risk Management},
  year = {2022},
  doi = {10.56142/2022.14.1.51}
}
Kostenlos starten →